Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-08-02
Summary
This project is a multicenter observational study that establishes a longitudinal cohort of patients with Alzheimer's disease and other dementias based on neuroimaging, molecular imaging, biological and digital markers to explore new solutions such as dementia disease mechanism, diagnosis, condition evaluation, and prognosis assessment.
Conditions
- Alzheimer Disease
- Image
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Principal Investigators
-
Gang Wang, PhD. MD. · RenJi Hospital
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-30
- Primary Completion
- 2029-07-30
- Completion
- 2029-08-30
Countries
- China
Study Locations
More Related Trials
-
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
NCT07089303 ·Status: RECRUITING
-
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
NCT01638949 ·Status: COMPLETED ·Phase: NA
-
Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD
NCT02225964 ·Status: COMPLETED
-
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
NCT06833645 ·Status: RECRUITING
-
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT05003830 ·Status: UNKNOWN
-
Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype
NCT02706210 ·Status: UNKNOWN
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 ·Status: RECRUITING
-
A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
NCT05527288 ·Status: COMPLETED ·Phase: NA
-
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
NCT04277767 ·Status: UNKNOWN
-
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
NCT06925178 ·Status: RECRUITING
-
Study to Understand Novel Biomarkers in Researching Dementia
NCT06547099 ·Status: RECRUITING
-
[18F]APN-1607 PET in Subjects With AD Compared to HC
NCT05542953 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimer's Disease
NCT04509271 ·Status: UNKNOWN
-
The Evolution and Prognosis of Moyamoya Disease
NCT05619068 ·Status: RECRUITING
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Renji Alzheimer's Disease Neuroimaging Cohort Study
NCT05433363 ·Status: UNKNOWN
-
Multimodal Ocular Imaging in Neurodegeneration
NCT03699644 ·Status: COMPLETED
-
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
NCT04575337 ·Status: RECRUITING
-
Blood Biomarkers for Screening of Alzheimer's Disease
NCT06477484 ·Status: RECRUITING
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease
NCT04926272 ·Status: UNKNOWN ·Phase: PHASE2
-
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT02740634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multimodal Biomarkers for Diagnosis and Prognosis in VCI
NCT04604600 ·Status: UNKNOWN ·Phase: PHASE3
-
Cerebellar ITBS Mode Transcranial Magnetic Stimulation for the Treatment of Alzheimer's Disease
NCT06379100 ·Status: COMPLETED ·Phase: NA